Siga Technologies (SIGA) Current Leases (2019 - 2025)
Siga Technologies' (SIGA) quarterly Current Leases came in at $595169.0 in Q4 2025, up 8.84% on a YoY basis from $546820.0 in Q4 2024, and up 2.15% quarter-over-quarter from $582666.0 in Q3 2025.
Analysis
Siga Technologies (SIGA) Current Leases (2019 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Current Leases for 7 consecutive years, with $595169.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Current Leases rose 8.84% year-over-year to $595169.0; the trailing twelve-month figure through Dec 2025 stood at $595169.0 (up 8.84% YoY), and the FY2025 full-year result was $595169.0, up 8.84% from the prior year.
- Current Leases rose to $595169.0 in Q4 2025 per SIGA's latest filing, from $582666.0 in the prior quarter.
- Across five years, Current Leases topped out at $595169.0 in Q4 2025 and bottomed at $393936.0 in Q1 2021.
- Historically, Current Leases has averaged $528741.2 across 5 years, with a median of $536627.0 in 2023.
- The sharpest annual moves came in 2021 and 2022: Current Leases declined 7.76% in 2021, then climbed 23.56% in 2022.
- Over 5 years, Current Leases stood at $466830.0 in 2021, then rose by 13.14% to $528170.0 in 2022, then rose by 6.79% to $564009.0 in 2023, then decreased by 3.05% to $546820.0 in 2024, then advanced by 8.84% to $595169.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $595169.0, $582666.0, and $570426.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 263.86 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 16.75 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 4.26 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 595,169.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 595,169.00 |
| Sep 30, 2025 | 582,666.00 |
| Jun 30, 2025 | 570,426.00 |
| Mar 31, 2025 | 558,651.00 |
| Dec 31, 2024 | 546,820.00 |
| Sep 30, 2024 | 535,234.00 |
| Dec 31, 2023 | 564,009.00 |
| Sep 30, 2023 | 554,732.00 |
| Jun 30, 2023 | 545,558.00 |
| Mar 31, 2023 | 536,627.00 |
| Dec 31, 2022 | 528,170.00 |
| Sep 30, 2022 | 519,198.00 |
| Jun 30, 2022 | 507,140.00 |
| Mar 31, 2022 | 486,752.00 |
| Dec 31, 2021 | 466,830.00 |
| Sep 30, 2021 | 496,683.00 |
| Mar 31, 2021 | 393,936.00 |
| Dec 31, 2020 | 449,940.00 |
| Sep 30, 2020 | 441,992.00 |
| Jun 30, 2020 | 434,132.00 |